|
Palm Beach County Hospitals Offer Important Advice for Coping with COVID-19
|
|
|
|
Dr. Bradley Lamm interviewed on CBS 12 on staying active during health crisis
|
|
|
|
Sam Barone of DMC interviewed on CBS 12 about eating healthy during COVID-19 pandemic
|
|
|
|
Dr. Shady Salib is interviewed on Fox 35 Orlando on COVID-19 symptoms
|
|
|
|
Dr Jason Sevald interviewed on WPTV on the Coronavirus
|
~~~~~~~
|
|
Nicklaus Children's Health System and Baptist Health South Florida Collaborate to Support Readiness for Anticipated COVID-19-Related Patient Surge
|
Nicklaus Children's Health System (NCHS) and
Baptist Health South Florida have signed a letter of agreement to collaborate in the weeks ahead with the shared goal of optimizing response to an anticipated regional surge of adult
COVID-19-related hospital admissions.
Under the agreement, effective
4.1.20,
Baptist Hospital and
Baptist Children's Hospital will transfer all children requiring inpatient admission to
Nicklaus Children's Hospital in order to prepare for the predicted influx of COVID-19-associated adult hospitalizations. This makes hospital beds, staff and equipment available for adult patient care at Baptist Hospital.
Baptist Hospital and
Miami Cancer Institute will continue to provide pediatric oncology services; Baptist Hospital,
Homestead Hospital, South Miami Hospital and
West Kendall Baptist Hospital will continue to provide neonatal intensive care (NICU) services; and Baptist Hospital,
Doctors Hospital, Fishermen's Community Hospital, Homestead Hospital,
Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital will continue to see pediatric patients in their emergency rooms. Any pediatric patients seen in the
Baptist Health emergency departments in Miami-Dade and Monroe counties requiring hospital admission will be transferred to Nicklaus Children's Hospital.
|
Miller School Physician Treats COVID-19 Patient with Nitric Oxide Therapy
|
A pulmonologist with the
University of Miami Health System and the Miller School of Medicine has initiated a new therapy for the first time in a patient with novel coronavirus
COVID-19 diagnosis. The treatment has the potential to delay the need for a ventilator.
Roger Alvarez, DO, MPH, assistant professor of pulmonology, began treatment on March 26 using the
INOpulse® inhaled nitric oxide system (iNO) from
Bellerophon Therapeutics, Inc., which was recently granted emergency expanded access for treating
COVID-19 patients by the
U.S. Food and Drug Administration (
FDA).
"INOpulse has the potential to be used as a viable treatment option for
COVID-19, based on previous studies that demonstrate the benefits of iNO in oxygenation and immune response," said Dr. Alvarez, who, in addition to his clinical practice, conducts basic, clinical, and translational research in pulmonary hypertension.
|
|
Do You Know a Healthcare Game Changer?
|
|
|
|
|
Publisher of:
Week in Review, Specialty Focus,
FHIweekly & Game Changers
Creator of:
The Healthcare Roundtable Series
INFORM | CONNECT | ENGAGE
|
|
|
